Pharma

Your Article Summary

See Latest Articles

Once-daily HIV Prevention Pill Shows Promise
Pharmacy Times, 10/18/06

A clinical trial of the HIV prevention drug Viread (tenofovir), which took place in Africa, showed promising results, as fewer people taking the once-daily pill became infected with HIV, compared with those who took a placebo. Family Health International conducted the trial with 859 women, many of whom were prostitutes. The women, none of whom had HIV at the beginning of the trial, were divided into 2 groups: 427 women received Viread and 432 received a placebo. All the women in the trial received sexual health counseling and condoms

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

 See all of Drug Trials